Mr. Hudson brings to the scPharmaceuticals Board over 37 years of relevant experience in accounting and auditing as a longtime partner at KPMG, LLP. Prior to his retirement, Mr. Hudson was the partner in charge of KPMG’s largest healthcare industry audit practice located in the Mid-Atlantic region. Over his career, Mr. Hudson also held senior positions with KPMG in the area of due-diligence and mergers and acquisitions services where his work was focused on high-growth companies in the healthcare industry. Mr. Hudson is active on the boards of numerous public and private healthcare companies. Fred has a deep accounting and finance background and has served as audit chair for a number of other private and public healthcare companies including Greater Baltimore Medical Center, Inc., Supernus Pharmaceuticals, and Aradigm Corporation. Mr. Hudson will act as an independent director and Chair the Audit Committee. Mr. Hudson is a graduate of Loyola University Maryland.